Oncolytics Biotech
Presence
Oncolytics Biotech is a company listed under the stock ticker ONC (CA).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Oncolytics Biotech
- Matthew Coffey, Director, President and Chief Executive Officer
- Bernd Seizinger, Director
- Wayne Pisano, Chairman of the Board
Popular executive movements at Oncolytics Biotech
- Jonathan Rigby has joined the company as Director (posted on September 12 2022).
Create your alert
to follow the executive moves at Oncolytics Biotech.
Biotechnology
Oncolytics Biotech has 2,182 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Biogen (United States (USA)).
Popular M&A news in Biotechnology
- Carmot Therapeutics has just announced a $150 Million fundraising (posted on June 1 2023).
- BenchSci has just announced a $70 Million fundraising (posted on May 30 2023).
- ElevateBio has just announced a $401 Million fundraising (posted on May 26 2023).
Popular contacts in Biotechnology
News
Press releases by Oncolytics Biotech
- Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® to Host Key Opinion Leader Webinar on Data from the Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer Being Presented at the Upcoming ASCO Annual Meeting :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® Reports First Quarter 2023 Financial Results and Operational Highlights :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® Announces Upcoming Oral Presentation on Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer at the ASCO Annual Meeting :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® to Participate in a Panel Presentation at Cantor Fitzgerald's The Future of Oncology Virtual Symposium :: Oncolytics Biotech, Inc. (ONCY)
- Oncolytics Biotech® Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights :: Oncolytics Biotech, Inc. (ONCY)
- View more press releases Close
Social media about Oncolytics Biotech
- Oncolytics Biotech on Wikipedia, Google News & Yahoo Finance
- Oncolytics Biotech on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Wayne Pisano 
Call Oncolytics Biotech at +1 403...
